Pointsbet Holdings Ltd
ASX:PBH
Pointsbet Holdings Ltd
ASX:PBH
Price:
0.97
AUD
-3%
Market Cap:
AU$337.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pointsbet Holdings Ltd
ASX:PBH
|
AU |
|
S
|
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
|
CN |
|
H
|
Hang Tai Yue Group Holdings Ltd
HKEX:8081
|
HK |
|
Luen Thai Holdings Ltd
HKEX:311
|
HK |
|
Immunovia AB (publ)
STO:IMMNOV
|
SE |
Income Statement
Earnings Waterfall
Pointsbet Holdings Ltd
Pointsbet Holdings Ltd
Income Statement
Pointsbet Holdings Ltd
Pointsbet Holdings Ltd
Currency: AUD
| Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
3
|
2
|
0
|
1
|
4
|
6
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
26
N/A
|
41
+60%
|
75
+84%
|
123
+64%
|
195
+58%
|
259
+33%
|
195
-24%
|
297
+52%
|
210
-29%
|
328
+56%
|
245
-25%
|
252
+3%
|
261
+4%
|
266
+2%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(15)
|
(25)
|
(37)
|
(71)
|
(107)
|
(142)
|
(95)
|
(149)
|
(105)
|
(164)
|
(116)
|
(116)
|
(124)
|
(130)
|
|
| Gross Profit |
11
N/A
|
16
+50%
|
38
+137%
|
52
+35%
|
88
+70%
|
117
+33%
|
101
-14%
|
149
+48%
|
106
-29%
|
164
+55%
|
130
-21%
|
136
+5%
|
137
+1%
|
136
-1%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(49)
|
(77)
|
(83)
|
(140)
|
(262)
|
(360)
|
(137)
|
(247)
|
(212)
|
(313)
|
(160)
|
(159)
|
(155)
|
(159)
|
|
| Selling, General & Administrative |
(47)
|
(74)
|
(78)
|
(133)
|
(249)
|
(336)
|
(126)
|
(227)
|
(178)
|
(249)
|
(132)
|
(130)
|
(127)
|
(133)
|
|
| Depreciation & Amortization |
(2)
|
(3)
|
(5)
|
(7)
|
(12)
|
(21)
|
(10)
|
(18)
|
(28)
|
(42)
|
(27)
|
(25)
|
(22)
|
(21)
|
|
| Other Operating Expenses |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(1)
|
(1)
|
(6)
|
(23)
|
(1)
|
(4)
|
(5)
|
(5)
|
|
| Operating Income |
(38)
N/A
|
(61)
-60%
|
(45)
+27%
|
(89)
-98%
|
(175)
-96%
|
(244)
-40%
|
(36)
+85%
|
(98)
-172%
|
(107)
-9%
|
(149)
-40%
|
(31)
+79%
|
(23)
+25%
|
(18)
+22%
|
(23)
-25%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(4)
|
(3)
|
3
|
(6)
|
(12)
|
(5)
|
15
|
24
|
14
|
9
|
(6)
|
(1)
|
0
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(15)
|
0
|
(2)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(42)
N/A
|
(64)
-52%
|
(41)
+35%
|
(95)
-129%
|
(188)
-98%
|
(249)
-32%
|
(21)
+92%
|
(74)
-260%
|
(108)
-45%
|
(140)
-30%
|
(39)
+72%
|
(24)
+39%
|
(18)
+25%
|
(23)
-28%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(42)
|
(64)
|
(41)
|
(95)
|
(188)
|
(249)
|
(21)
|
(74)
|
(108)
|
(141)
|
(40)
|
(24)
|
(18)
|
(23)
|
|
| Net Income (Common) |
(42)
N/A
|
(64)
-52%
|
(41)
+35%
|
(95)
-129%
|
(188)
-98%
|
(249)
-32%
|
(268)
-8%
|
(446)
-67%
|
(276)
+38%
|
(313)
-13%
|
(42)
+86%
|
(23)
+45%
|
(18)
+22%
|
(23)
-27%
|
|
| EPS (Diluted) |
-0.33
N/A
|
-0.46
-39%
|
-0.27
+41%
|
-0.52
-93%
|
-0.94
-81%
|
-1
-6%
|
-1.04
-4%
|
-1.45
-39%
|
-0.9
+38%
|
-0.99
-10%
|
-0.12
+88%
|
-0.07
+42%
|
-0.05
+29%
|
-0.07
-40%
|
|
Switch to:
Switch to:
See Also
Discover More
